Stocktoria
NRC HEALTH NRC
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1997-10-01
NRC HEALTH financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M |
| SG&A expense | $54.8M | $44.9M | $46.6M | $42.7M | $39.0M |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M |
| Interest expense | — | $2.6M | $862,000 | $1.2M | $1.7M |
| Income tax | $6.2M | $7.9M | $9.0M | $11.0M | $11.2M |
| Operating cash flow | $26.4M | $34.6M | $38.1M | $36.3M | $46.3M |
| Free cash flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M |
| Cash & equivalents | $4.1M | $4.2M | $6.7M | $25.0M | $54.4M |
| Total assets | $134.9M | $132.5M | $122.4M | $130.5M | $157.5M |
| Total liabilities | $120.9M | $101.3M | $73.5M | $58.4M | $72.2M |
| Shareholders' equity | $14.0M | $31.3M | $49.0M | $72.0M | $85.3M |
| EPS (diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
Source: SEC EDGAR filings · CIK 0000070487 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.